Mather Group, Llc. Amgen Inc Transaction History

Mather Group, Llc.

$7.74 Billion
Q3 2024

A detailed history of Mather Group, Llc. transactions in Amgen Inc stock. As of the latest transaction made, Mather Group, Llc. holds 8,964 shares of AMGN stock, worth $2.36 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

8,964

Previous 9,293 3.54%

Holding current value

$2.36 Million

Previous $2.9 Million 0.52%

% of portfolio

0.04%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$309.38 - $337.38 $101,786 - $110,998	-329 Reduced 3.54%	8,964 $2.89 Million
Q2 2024 Jul 08, 2024	SELL	$262.75 - $319.31 $794,818 - $965,912	-3,025 Reduced 24.56%	9,293 $2.9 Million
Q1 2024 Apr 08, 2024	BUY	$268.87 - $324.56 $15,056 - $18,175	56 Added 0.46%	12,318 $3.5 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $293,032 - $330,575	1,146 Added 10.31%	12,262 $3.53 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $142,559 - $176,991	652 Added 6.23%	11,116 $2.99 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $400,256 - $473,295	1,868 Added 21.73%	10,464 $2.32 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $1.01 Million - $1.23 Million	4,485 Added 109.1%	8,596 $2.08 Million
Q4 2022 Mar 10, 2023	SELL	$229.03 - $291.01 $49,470 - $62,858	-216 Reduced 4.99%	4,111 $1.08 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $51,625 - $58,224	230 Added 5.61%	4,327 $975,000
Q2 2022 Aug 16, 2022	BUY	$230.71 - $256.74 $20,994 - $23,363	91 Added 2.27%	4,097 $997,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $883,877 - $977,799	-4,031 Reduced 50.16%	4,006 $969,000
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $37,389 - $42,788	188 Added 2.4%	8,037 $1.81 Million
Q3 2021 Nov 04, 2021	BUY	$212.27 - $248.7 $479,305 - $561,564	2,258 Added 40.39%	7,849 $1.67 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $264,879 - $293,864	1,134 Added 25.44%	5,591 $1.36 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $210,592 - $245,411	949 Added 27.05%	4,457 $1.11 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $25,100 - $29,889	116 Added 3.42%	3,508 $807,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $39,186 - $43,578	167 Added 5.18%	3,392 $862,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $219,766 - $269,684	1,111 Added 52.55%	3,225 $761,000
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $79,638 - $105,622	437 Added 26.06%	2,114 $429,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $317,305 - $407,846	1,677 New	1,677 $404,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.

Account